The Farrah Fawcett Foundation

The Farrah Fawcett Foundation operates as an invitation-only grantmaker — IRS filings explicitly note it funds preselected organizations only and does not accept unsolicited applications. This structure shapes every engagement strategy: the path to funding runs entirely through relationship-building, not cold proposals.

The foundation channels its $22.6M asset base across two distinct grantee tiers. The first is institutional research partnerships with major national cancer organizations. Stand Up to Cancer has received $737,500 across three grants, the Entertainment Industry Foundation $650,000 across three grants, and the American Cancer Society $487,500 across three grants. These are ongoing, co-branded relationships — the SU2C–Farrah Fawcett Foundation HPV Translational Research Team Grant and the SU2C–Fanconi Anemia Research Fund–Farrah Fawcett Foundation Head and Neck Cancer Research Team are signature collaborative initiatives. The second tier consists of patient assistance grants to hospital foundations and regional health systems that establish a named Farrah Fawcett Fund for Patient Assistance. Current fund sites include Vanderbilt-Ingram Cancer Center ($80,000 cumulative), Agnesian Healthcare Foundation ($64,000), Children's Hospital Los Angeles ($49,000), Karmanos Cancer Institute ($46,000), and Altru Health Foundation ($39,000).

The foundation is run by a small, mission-driven team. President Alana Stewart — a close personal friend of Farrah Fawcett — has led the organization since inception and earns $145,000 annually, reflecting her central leadership role. Christine Romeo (Director of Communications, $111,000) handles all external relations. Board members Lawrence Piro (oncologist), Kim Swartz, and Shira Nachshon serve voluntarily. Decisions flow through this tight inner circle.

First-time applicants should understand there is no online portal, no published RFP, and no defined grant cycle with public deadlines. Effective entry points are: attending the annual Dallas fundraiser (September 24, 2026 next event); positioning your institution around HPV or anal cancer research with documented patient outcomes; reaching out to Christine Romeo at the foundation's public email for an introductory conversation; or seeking a warm referral through Stand Up to Cancer or the Entertainment Industry Foundation.

For cancer hospitals and regional health systems, the highest-probability path is proposing a Farrah Fawcett Fund for Patient Assistance at your institution — the model is already established at five sites and offers a clear template the foundation can replicate without reinventing its grantmaking approach.

The Farrah Fawcett Foundation has grown substantially since its 2007 founding, with total assets rising from $5.2M in FY2011 to $22.6M in FY2023. Annual grants paid have fluctuated year to year: $262K (2011), $294K (2012), $347K (2013), $467K (2014), $573K (2015), then a peak of $703K in FY2022, with FY2023 at $627K. Total giving — which includes program expenses beyond direct grants — reached $1.74M in FY2023 and $1.49M in FY2022, indicating the foundation runs meaningful program operations alongside its grantmaking.

The grantee database covers 41 recorded grants totaling approximately $2.38M, with a raw average of $57,943. However, that figure is skewed sharply by three dominant institutional partners: Stand Up to Cancer ($737,500 over 3 grants), Entertainment Industry Foundation ($650,000 over 3 grants), and American Cancer Society ($487,500 over 3 grants). These three grantees account for roughly $1.875M — nearly 79% of all recorded grantmaking. Excluding them, the remaining 12 grantees received an average of about $40,000 in total cumulative grants.

For patient assistance and regional health system grantees, the realistic range is $2,500–$40,000, with a median of $12,500 and an average of approximately $15,417 per transaction. Multi-year grant relationships are common: Agnesian Healthcare Foundation received 4 separate grants; Children's Hospital Los Angeles and Karmanos Cancer Institute each received 4 grants; Altru Health Foundation received 3.

Geographically, California dominates with 19 grants (largely to Los Angeles-area institutions), followed by New York (5), Michigan (4), Wisconsin (4), Texas (4), North Dakota (3), and Tennessee (2). The Texas footprint is growing, anchored by the annual Dallas fundraiser.

By program area, cancer research commands the vast majority of institutional dollar volume, while patient assistance grants are more numerous but individually smaller. HPV-related cancer research — including anal, oropharyngeal, head and neck, and cervical cancers — is the stated primary focus. Revenue trends are healthy: net investment income reached $1.24M in FY2023, supplemented by $557K in contributions, suggesting the foundation can sustain its current grantmaking pace. The 2025 Tex-Mex Fiesta's $1 million research commitment signals an elevated pipeline for FY2026 disbursements.

The following peer foundations hold assets comparable to the Farrah Fawcett Foundation ($22–25M range) and share the Philanthropy & Grantmaking NTEE classification:

Among this asset-comparable peer group, the Farrah Fawcett Foundation stands out for its narrow, mission-driven focus and celebrity-powered fundraising infrastructure. Most peers are general philanthropic vehicles with no published specialty program or external-facing grant pipeline. The Farrah Fawcett Foundation's grants paid in FY2023 ($627K) represent a 2.8% payout rate on assets — below the federal 5% private foundation minimum on a grants-paid basis alone, but total giving including program expenses reached $1.74M (7.7% of assets), comfortably exceeding the threshold. Its partnership infrastructure with Stand Up to Cancer and the American Cancer Society gives it institutional leverage significantly beyond what its $22.6M asset base would typically support.

The October 30, 2025 Tex-Mex Fiesta at The Rustic in Dallas was the foundation's most consequential recent event. Celebrity co-chairs included Jaclyn Smith, Linda Gray, and Alana Stewart, with honorary co-chairs Perry Henderson and Joan Schnitzer Levy. Notable attendees included George Hamilton, Morgan Fairchild, Donna Mills, Dallas Cowboys quarterback Dak Prescott, and philanthropist Eugenia 'Gene' Jones, who received special recognition at the event.

The most significant programmatic announcement of 2025 was the foundation's $1 million commitment to fund HPV-related cancer research — specifically targeting anal and oropharyngeal cancers — through an Innovation Summit co-organized with Stand Up to Cancer. Funds raised at the 2025 Fiesta also supported the American Cancer Society's Hope Lodge patient lodging program.

On the research side, the SU2C–Fanconi Anemia Research Fund–Farrah Fawcett Foundation Head and Neck Cancer Research Team remains active, funding multidisciplinary translational research across institutions including Dana Farber Cancer Institute, UCLA Health, and Vanderbilt University, targeting HPV-related head and neck squamous cell carcinoma.

Looking ahead, the foundation has confirmed 'A Night to Remember' for September 24, 2026 at The Rustic in Dallas — contact texmex@jamesgrp.net for event inquiries. No public RFP or grant application windows have been announced for 2026. Total giving since inception now exceeds $1.5M to HPV-related cancer research alone per the foundation's published figures.

Because the Farrah Fawcett Foundation explicitly funds preselected organizations only, every tip here is relationship-oriented rather than process-oriented. Traditional 'apply and wait' strategies will not work.

Lead with HPV specificity. The foundation's entire modern identity centers on HPV-related cancers — anal, cervical, oropharyngeal, head and neck. Any institutional outreach must foreground your HPV cancer research, patient population, or prevention programming. Generic oncology framing will not resonate with a leadership team built around Farrah Fawcett's personal experience with anal cancer.

Attend the annual Dallas gala. The Tex-Mex Fiesta (next: September 24, 2026, 'A Night to Remember' at The Rustic) is the foundation's primary public gathering. Alana Stewart, Christine Romeo, board oncologist Lawrence Piro, and major institutional donors are all present. Contact texmex@jamesgrp.net to purchase tickets or inquire about sponsorship.

Propose a named patient assistance fund. The Farrah Fawcett Fund for Patient Assistance is a replicable model already operating at Vanderbilt-Ingram, Children's Hospital LA, Agnesian Healthcare Foundation, Karmanos Cancer Institute, and Altru Health Foundation. Approaching the foundation with a specific proposal — citing your HPV cancer patient volume, their unmet financial needs, and how the named fund would be administered — gives leadership a concrete, low-friction ask.

Make an introduction first, not a funding request. Contact Christine Romeo at info@thefarrahfawcettfoundation.org or (310) 277-7351. Describe your institution's mission and patient population in two to three sentences. Ask for a call to explore alignment — do not request money in initial contact.

Pursue a warm introduction through existing grantees. Stand Up to Cancer, the Entertainment Industry Foundation, and the American Cancer Society are the foundation's three largest long-term grantees. A referral from any of them carries significant weight with foundation leadership, particularly for research institutions.

Align with Farrah's personal legacy. Proposals referencing alternative and integrative approaches to cancer care, the patient dignity dimension of anal cancer treatment, and under-researched cancer types will resonate most with Alana Stewart's relationship to the foundation's origins.

Timing. Relationship activity peaks around the annual October/September gala. Follow-up outreach in November–December, while foundation leadership is engaged with new relationships, is optimal for patient assistance fund proposals.